<DOC>
	<DOCNO>NCT01047982</DOCNO>
	<brief_summary>Myo-Inositol classified member vitamin B complex . It constituent live cell widespread many food . It involve number biological process , include insulin signal transduction , result modulate insulin sensitivity . This prospective , randomize , double center , placebo-controlled study . Two hundred twenty obese pregnant woman include trial , informed consent , assume randomly 2 g myo-inositol twice day placebo 12-13th week gestation delivery . Then , perform Oral Glucose Tolerance Test ( OGTT ) 24-28th week gestation . Records delivery ( gestational age , neonatal weight ... ) register .</brief_summary>
	<brief_title>Myo-inositol Obese Pregnant Women</brief_title>
	<detailed_description />
	<mesh_term>Diabetes , Gestational</mesh_term>
	<mesh_term>Inositol</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>Obese pregnant woman : BMI &gt; 30 Kg/cm2 first trimester fast glycaemia &lt; 126 mg/dl single pregnancy Pregnant woman BMI &lt; 30 Kg/cm2 first trimester fast glycaemia &gt; 126 mg/dl previous gestational diabetes twin pregnancy pregestational diabetes associate therapy corticosteroid</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>gestational diabetes</keyword>
	<keyword>macrosomia</keyword>
	<keyword>hypertension pregnancy</keyword>
	<keyword>HOMA-IR</keyword>
	<keyword>obesity</keyword>
</DOC>